Managing the burden of Type 2 diabetes: an international survey of physicians

Southwell, Angela; Eckland, D.J.A.

doi:10.1002/pdi.1960140710

Cited by 11 publications

(6 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite the lower mean age of patients and the shorter duration of diabetes as compared with those currently observed in European countries (mean duration of diabetes of 9.3 years was reported) (33), an interesting finding concerned the frequencies of diabetes complications and comorbidities reported by practitioners, which were similar to those observed in western countries (34).…”

Section: Diabetes Managementsupporting

confidence: 65%

A Population-Based Study of Diabetes and Its Characteristics During the Fasting Month of Ramadan in 13 Countries

Salti

Bénard²,

Detournay³

et al. 2004

Diabetes Care

617

640

View full text Add to dashboard Cite

OBJECTIVE -The aim of this study was to assess the characteristics and care of patients with diabetes in countries with a sizable Muslim population and to study diabetes features during Ramadan and the effect of fasting.RESEARCH DESIGN AND METHODS -This was a population-based, retrospective, transversal survey conducted in 13 countries. A total of 12,914 patients with diabetes were recruited using a stratified sampling method, and 12,243 were considered for the analysis.RESULTS -Investigators recruited 1,070 (8.7%) patients with type 1 diabetes and 11,173 (91.3%) patients with type 2 diabetes. During Ramadan, 42.8% of patients with type 1 diabetes and 78.7% with type 2 diabetes fasted for at least 15 days. Less than 50% of the whole population changed their treatment dose (approximately one-fourth of patients treated with oral antidiabetic drugs [OADs] and one-third of patients using insulin). Severe hypoglycemic episodes were significantly more frequent during Ramadan compared with other months (type 1 diabetes, 0.14 vs. 0.03 episode/month, P ϭ 0.0174; type 2 diabetes, 0.03 vs. 0.004 episode/month, P Ͻ 0.0001). Severe hypoglycemia was more frequent in subjects who changed their dose of OADs or insulin or modified their level of physical activity.CONCLUSIONS -The large proportion of both type 1 and type 2 diabetic subjects who fast during Ramadan represent a challenge to their physicians. There is a need to provide more intensive education before fasting, to disseminate guidelines, and to propose further studies assessing the impact of fasting on morbidity and mortality.

show abstract

Section: Diabetes Managementsupporting

confidence: 65%

A Population-Based Study of Diabetes and Its Characteristics During the Fasting Month of Ramadan in 13 Countries

Salti

Bénard²,

Detournay³

et al. 2004

Diabetes Care

617

640

View full text Add to dashboard Cite

show abstract

“…[18] Southwell et al in their study found that 40% of the diabetics exhibiting hypercholesterolemia. [16] The above studies support our findings.…”

Section: Peripheral Vascular Diseasesupporting

confidence: 83%

“…In the present study, 15.34% (23/150) of the patients had subclinical hypothyroidism and 1.5%% (2/150) of the patients sub clinical hyperthyroidism, and 10.67% (16) had overt hypothyroidism and 1.5%(2) had overt hyperthyroidism…”

Section: Distribution Of Thyroid Abnormalitiesmentioning

confidence: 89%

“…In the present study, 16.7% (25 in number) of diabetic patients had coronary artery disease. Type 2 diabetes increases relative risk of cardiovascular disease two-to fourfold compared with the risk in the general population.…”

Section: Co-morbid Diseasesmentioning

confidence: 96%

“…This study was almost like that of South well et al who found that prevalence of diabetic retinopathy was 15%. [16] Peripheral Neuropathy None of the diabetic patients in our study had peripheral neuropathy…”

Section: Retinopathymentioning

confidence: 99%

See 2 more Smart Citations

Study of Thyroid Profile by Using Ultra Sensitive 3<sup>rd</sup> Generation Thyroid Assay in Type 2 Diabetes Mellitus Patients in a Tertiary Care Centre

Ladda¹,

Biradar²

2017

rjms

View full text Add to dashboard Cite

Objectives: There is a greater propensity for occurrence of thyroid dysfunction in patients with type 2 diabetes mellitus. A study was conducted to find out the prevalence and distribution of thyroid disorders in patients with type 2 diabetes mellitus. An attempt was made to evaluate the relationship between glycemic control and occurrence of altered thyroid functions in type 2 diabetes mellitus. Material and methods: The study material consisted 150 patients with known type 2 diabetes mellitus or newly detected type 2 diabetes mellitus without known thyroid disorders. 3rd generation TSH assay was utilised to screen the patients with diabetes to know the status of thyroid profile. Results: Among 150 cases of Type 2 diabetes 43(28.67%) had abnormal thyroid functions. Of these 23(15.34%) had subclinical hypothyroidism 16 (10.66%) overt hypothyroidism and 2(1.33%) each had subclinical and overt hypothyroidism. Thyroid disorders were noted more commonly among those having diabetes over a period of 5 years. There was a significant correlation between abnormal thyroid profile and family history of diabetes, BMI and serum lipid profile. There was significant co relation between diabetic control and abnormal thyroid profile. Conclusion: Screening has to be performed to detect the presence of thyroid dysfunction in type 2 diabetes mellitus patients as the progression to overt thyroid dysfunction is associated with significant morbidity including the adverse effects on glycemic control, and lipid profile.

show abstract

Limitations of treatments available for the management of Type 2 diabetes: Results from an international survey of physicians

Southwell¹,

Eckland

1998

Pract Diab Int

View full text Add to dashboard Cite

This is the second paper presenting information from a prospective, cross‐sectional survey of patients with Type 2 diabetes in France, Germany and the UK. An anonymised physician‐completed diary card was used to collect data about the treatment of 3,043 drug‐treated patients with Type 2 diabetes. The most common antidiabetic treatment, taken by 48% of patients aged over 60 years, was sulphonylurea monotherapy. The most frequent combination was a sul‐phonylurea with a biguanide. Nearly 40% of patients who had been diagnosed more than 25 years previously were receiving insulin therapy alone. In 70% of patients the reason for changing therapy in the previous five years was insufficient glycaemic control. Hypoglycaemia was the most common reason for treatment change in patients prescribed insulin with a sulphonylurea. One third of patients experienced at least one problem with their current treatment. The number of problems was related to the number of concomitant treatments. Hypoglycaemia, gastrointestinal problems and weight gain were the most common adverse events. These occurred most frequently in patients with severe Type 2 diabetes. This survey gives an insight into the nature of treatment, history of management, and problems associated with the current therapeutic choices for Type 2 diabetes.

show abstract

Managing the burden of Type 2 diabetes: an international survey of physicians

Cited by 11 publications

References 41 publications

A Population-Based Study of Diabetes and Its Characteristics During the Fasting Month of Ramadan in 13 Countries

A Population-Based Study of Diabetes and Its Characteristics During the Fasting Month of Ramadan in 13 Countries

Study of Thyroid Profile by Using Ultra Sensitive 3<sup>rd</sup> Generation Thyroid Assay in Type 2 Diabetes Mellitus Patients in a Tertiary Care Centre

Limitations of treatments available for the management of Type 2 diabetes: Results from an international survey of physicians

Contact Info

Product

Resources

About